Kevin G. Shaw
Sr VP, General Counsel · NextCure, Inc.
Individual
- 2026
- Feb 3, 2026
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin G. Shaw files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $1.71M in NXTC purchases and sales in the last 12 months
- Simcere Zaiming, Inc. - $185K in NXTC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin G. Shaw?
Kevin G. Shaw is a corporate insider, tracked as Sr VP, General Counsel of NextCure, Inc. (NXTC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kevin G. Shaw last file a Form 4?
The only primary Form 4 on record is dated 3 February 2026.